News & Insights
PRESS RELEASE: Inteliquet™ Announces Presbyterian Healthcare Services to Join Consortium to Drive Better Patient Matching in Clinical Trials
"Presbyterian has earned a reputation for investing in teams and a process that in turn take the time to understand and serve patients as...
PRESS RELEASE: Inteliquet™ Announces Comprehensive Hematology and Oncology to Join Consortium to Drive Better Patient Matching in Clinical Trials
"Patients tend to choose Consortium member centers like Comprehensive Hematology and Oncology, because they prize access to physicians who draw from...
We announced findings from David Hadley’s abstract at ASCO 2021
David explored Real World Data on outcomes of successive regimens involving anti-PDx-1 in advanced and metastatic non-small cell lung cancer. He...
Health IT Answers: In 2021, Cancer Researchers Can Make Up for Lost Time with Better Patient Matching to Clinical Trials
“Cancer patients deserve our best efforts to provide expanded access to potentially life-saving clinical trial and treatment options. Digital...
Industry Tech Insights Recognizes Inteliquet™: Top 10 Companies Revolutionizing Healthcare
2020 uncovered unprecedented challenges in healthcare, such as workforce and supply shortages and a shift to remote monitoring when available....
Spotlight: Olga Stanko, Director of Product Development
Olga Stanko is Director of Product Development at Inteliquet™. She is responsible for working with our life sciences and healthcare clients to...
PRESS RELEASE: Inteliquet™ Announces Presbyterian Healthcare Services to Join Consortium to Drive Better Patient Matching in Clinical Trials
"Presbyterian has earned a reputation for investing in teams and a process that in turn take the time to understand and serve patients as...
PRESS RELEASE: Inteliquet™ Announces Comprehensive Hematology and Oncology to Join Consortium to Drive Better Patient Matching in Clinical Trials
"Patients tend to choose Consortium member centers like Comprehensive Hematology and Oncology, because they prize access to physicians who draw from...
We announced findings from David Hadley’s abstract at ASCO 2021
David explored Real World Data on outcomes of successive regimens involving anti-PDx-1 in advanced and metastatic non-small cell lung cancer. He...
Health IT Answers: In 2021, Cancer Researchers Can Make Up for Lost Time with Better Patient Matching to Clinical Trials
“Cancer patients deserve our best efforts to provide expanded access to potentially life-saving clinical trial and treatment options. Digital...
Industry Tech Insights Recognizes Inteliquet™: Top 10 Companies Revolutionizing Healthcare
2020 uncovered unprecedented challenges in healthcare, such as workforce and supply shortages and a shift to remote monitoring when available....
Spotlight: Olga Stanko, Director of Product Development
Olga Stanko is Director of Product Development at Inteliquet™. She is responsible for working with our life sciences and healthcare clients to...
How Healthcare Organizations Can Evaluate an Approach to EMR Integration
In 2020, we kicked off a three-part blog series examining the challenges of EMR interrogation and the best time to interrogate EMRs for clinical...
Clinical Research News — There’s Got To Be A Better Way to Fight Cancer When Everything Else Is Falling Apart
COVID-19 has disrupted healthcare in myriad ways. It includes treatment options that may be part of clinical trials may be taken off the table.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry dedicated to delivering actionable insights. Learn more at www.iqvia.com.
